Name | 4-(1-Methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-Imidazole-5-carboxylic acid(5-methyl-2-oxo-1,3-dioxol-4-yl)methylester |
Synonyms | Olmesartan Medoxomil-3 Olmesartan Medoxomil Dehydro Olmesartan medoxomil impurity I Olmesartan Medoxomil EP Impurity C Olmesartan Medoxomil EP Impurity C (Dehydro Impurity), RNH-6373 4-(1-Methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]Methyl]- (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(prop-1-en-2-yl)-2-propyl-1H-imidazole-5-carboxylate 4-(1-methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-Imidazole-5-carboxylic acid(5-methyl-2-oxo-1,3-dioxol-4-yl)methy 4-(1-Methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-Imidazole-5-carboxylic acid(5-methyl-2-oxo-1,3-dioxol-4-yl)methylester |
CAS | 879562-26-2 |
Molecular Formula | C29H28N6O5 |
Molar Mass | 540.57 |
Density | 1.34±0.1 g/cm3(Predicted) |
Boling Point | 774.0±70.0 °C(Predicted) |
pKa | 4.16±0.10(Predicted) |
Storage Condition | 2-8℃ |